<DOC>
	<DOCNO>NCT02030457</DOCNO>
	<brief_summary>This study design compare systemic exposure orally inhale beclomethasone dipropionate inhalation aerosol deliver via BAI deliver via MDI .</brief_summary>
	<brief_title>A Study Investigate Pharmacokinetics Safety Beclomethasone Dipropionate Administered Breath-Actuated Inhaler Metered-Dose Inhaler Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>The subject man woman 18 45 year age SV . The subject assess good health base screen examination include medical history , physical examination ( include complete oropharyngeal examination ) , ECG assessment , clinical laboratory result ( ie , serum chemistry , hematology , urinalysis ) . If female , subject currently pregnant , breast feeding , attempt become pregnant ( 30 day SV throughout duration study 30 day subject 's last visit ) , nonchildbearing potential , define follow : premenarche least 1 year postmenopausal surgically sterile ( tubal ligation , bilateral oophorectomy , salpingectomy , hysterectomy ) congenital sterility diagnose infertile undergoing treatment reverse infertility childbearing potential , negative serum pregnancy test , willing commit use consistent acceptable method birth control define duration study : systemic contraception use least 1 month SV include birth control pill , transdermal patch ( Ortho Evra® , Janssen Pharmaceuticals Inc. , equivalent ) , vaginal ring ( NuvaRing® , Merck &amp; Co. , Inc. , equivalent ) , levonorgesterel implant ( Norplant® , Population Council , equivalent ) , injectable progesterone ( DepoProvera® , Pfizer Inc. , equivalent ) double barrier method ( condom , cervical cap , diaphragm , vaginal contraceptive film spermicide ) intrauterine device ( IUD ) low failure rate define less 1 % per year monogamous vasectomized male partner samesex female partner childbearing potential sexually active , negative serum pregnancy test , willing commit use consistent acceptable method birth control define duration study , event subject become sexually active . If male , subject willing commit acceptable method birth control duration study , 3 month dose , exclusively samesex partner . Subject normal body weight evidenced BMI least 18 30 kg/m2 ( ≥18 ≤30 kg/m2 ) , body weight 50 kg ( &gt; 50 kg ) . The BMI calculate follow : weight ( kg ) /height2 ( ) . Subject concomitant condition treatment could interfere study conduct , influence interpretation study observations/results , put subject increase risk study . Other criterion may apply , please contact investigator information . Subject clinically relevant abnormality clinical chemistry , hematology laboratory variable . Subject irregular day/nighttime rhythm daily living habit ( eg , night work repeat travel place belong different time zone ) . Subject treat known cytochrome P450 3A4 ( CYP3A4 ) inhibitor inducer ( eg , clarithromycin , ketoconazole , ritonavir , barbiturate , phenothiazine , cimetidine ) within 30 day Screening Visit ( SV ) . Subject exposed systemic corticosteroid ( past 60 day ) intranasal/orally inhaled corticosteroid ( past 30 day ) indication , chronic intermittent ; subject underlying condition reasonably expect require treatment corticosteroid course study . Subject use topical corticosteroid concentration excess 1 % hydrocortisone equivalent within 30 day SV ; use topical hydrocortisone equivalent concentration cover great 20 % body surface ; use topical corticosteroid occlusive dressing ; underlying condition ( judged investigator ) reasonably expect require treatment preparation course study . Subject use prohibit medication ( see Section 5.3 ) within prescribed period SV . Subject currently smoker use tobacco product within 1 year &gt; 10pack/year smoke history ( ie , equivalent smoke 1 pack per day per 10 year ) . Subject piercings tongue , lip , mouth . Other criterion may apply , please contact investigator information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>